Clinical Trial: A Multicenter Study Using Routine Blood Test Results Before Surgery to Predict the Pathological Type of Growth Hormone-Producing Pituitary Tumors (China)

Posted On: 2026-11-12

China, Nov. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter Study Using Routine Blood Test Results Before Surgery to Predict the Pathological Type of Growth Hormone-Producing Pituitary Tumors'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136464

Registration Time: 2026/11/11

Type: Observational study

Primary Sponsor: Fuzhou University Affiliated Provincial Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=351142

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

Clinical Trial: A Multicenter Study Using Routine Blood Test Results Before Surgery to Predict the Pathological Type of Growth Hormone-Producing Pituitary Tumors (China)